Veraxa Biotech AG - Post de-SPAC VRXA
NASDAQ VRXA
$1.19 -0.06 (-4.80%)
At close: Oct 1, 2026 · 4:00 PM EDT

Veraxa Biotech AG - Post de-SPAC (VRXA) Market Capitalization (2024 - 2025)

Updated

Veraxa Biotech AG - Post de-SPAC (VRXA) reported Market Capitalization of $154.45 million for the quarter ended Dec 31, 2025, up 9.7% from $140.8 million a year earlier.

Analysis

Veraxa Biotech AG - Post de-SPAC (VRXA) Market Capitalization (2024 - 2025) Analysis & Trends

  • By year, Market Capitalization came in at $140.8 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Veraxa Biotech AG - Post de-SPAC 18.09 Mn 14.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 154.45 Mn
Dec 31, 2024 140.80 Mn
API Access

Veraxa Biotech AG - Post de-SPAC Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=VRXA&period=max&api_key=YOUR_API_KEY